Histopathological characteristics of alcoholic liver injury in cases with serum HCV markers
Uchikoshi, T.; Maeyama, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 858-865
1995
ISSN/ISBN: 0047-1852 PMID: 7563891 Document Number: 453528
Document emailed within 1 workday
Related Documents
Baldi, E.; Burra, P.; Plebani, M.; Salvagnini, M. 1993: Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease Italian Journal of Gastroenterology 25(8): 429-432Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T. 1985: Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174
Swerdlow, M.A.; Chowdhury, L.N. 1984: IgA deposition in liver in alcoholic liver disease. An index of progressive injury Archives of Pathology and Laboratory Medicine 108(5): 416-419
Kudo, M.; Ikekubo, K.; Yamamoto, K.; Hino, M.; Ibuki, Y.; Tomita, S.; Komori, H.; Orino, A.; Todo, A. 1989: Focal fatty infiltration of the liver in acute alcoholic liver injury: hot spots with radiocolloid SPECT scan American Journal of Gastroenterology 84(8): 948-952
Ruiz del Arbol, L.; Moreira, V.F.; Pascasio, J.M.; González Martín, J.A.; Larraona, J.L.; Simón, M.A.; Suárez, E.; Barcena, R.; Bueno, R. 1985: Serum markers of hepatitis B virus infection in alcoholic hepatic disease Revista Clinica Espanola 177(8): 390-393
Boron-Kaczmarska, A.; Hryniewicz, A.; Kemona, A.; Szabados, A.; Puch, U.; Chrostek, L.; Szmitkowski, M. 1992: Influence of endotoxin on experimental post-alcoholic liver injury Acta Physiologica Hungarica 79(4): 399-408
Wu, G.-L.; Chen, J.; Yu, G.-Y.; Li, J.-P.; Lu, W.-W. 2008: Effect of puerarin on levels of TGF-beta1 and alpha-SMA in rats with alcoholic injury liver Zhongguo Zhong Yao Za Zhi 33(19): 2245-2249
Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Anand, K.K.; Chand, D.; Ghatak, B.J. 1979: Protective effect of alcoholic extract of Indigofera tinctoria Linn. in experimental liver injury Indian Journal of Experimental Biology 17(7): 685-687
Severova, M.M.; Saginova, E.A.; Galliamov, M.G.; Ermakov, N.V.; Rodina, A.V.; Fomin, V.V.; Mukhin, N.A. 2012: Clinicopathogenetic characteristics of cardiorenal syndrome in non-alcoholic fatty liver disease Terapevticheskii Arkhiv 84(6): 15-20
Swiatkowska-Stodulska, R.; Bakowska, A. 2004: Serum interleukin-6 concentrations in patients with alcoholic liver disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(99): 255-259
Abenavoli, L.; Milic, N.; Luigiano, C. 2014: Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease Minerva Medica 105(2): 175
Jeyaratnaganthan, N.; Grønbaek, H.; Holland-Fischer, P.; Espelund, U.; Chen, J.-W.; Flyvbjerg, A.; Vilstrup, H.; Frystyk, J. 2010: Ascites from patients with alcoholic liver cirrhosis contains higher IGF-i bioactivity than serum Clinical Endocrinology 72(5): 625-632
Sakizono, K.; Oita, T.; Eto, M.; Bito, S.; Takegawa, H.; Kasakura, S. 2002: Studies on the mechanism of elevation of serum PIVKA-Ii levels in alcoholic liver cirrhosis Rinsho Byori. Japanese Journal of Clinical Pathology 50(3): 289-295
Borowsky, S.A.; Lieberman, J.; Strome, S.; Sastre, A. 1982: Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease Archives of Internal Medicine 142(5): 893-895
Darmawan, G.; Hamijoyo, L.; Hasan, I. 2017: Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis Acta Medica Indonesiana 49(2): 136-147
Abenavoli, L.; Luigiano, C.; Guzzi, P.H.; Milic, N.; Morace, C.; Stelitano, L.; Consolo, P.; Miraglia, S.; Fagoonee, S.; Virgilio, C.; Luzza, F.; De Lorenzo, A.; Pellicano, R. 2014: Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease Panminerva Medica 56(2): 189-193
Kazimierska, E.; Czestochowska, E. 2003: Serum homocysteine, vitamin B12 and folic acid concentrations in patients with alcoholic liver cirrhosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(86): 140-143
Tahan, V.; Canbakan, B.; Balci, H.; Dane, F.; Akin, H.; Can, G.; Hatemi, I.; Olgac, V.; Sonsuz, A.; Ozbay, G.; Yurdakul, I.; Senturk, H. 2008: Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk Hepato-Gastroenterology 55(85): 1433-1438
Ćulafić-Vojinović, V.; Ćulafić, .; Ignjatović, S.; Petakov, M.; Nikolić, M..; Vasić, J.; Mirković, D.; Mijač, D.; Štulić, M. 2013: The Clinical Importance of Biochemical Bone Markers in Patients with Alcoholic and Viral Liver Cirrhosis / Klinički Značaj Biohemijskih Koštanih Markera Kod Pacijenata Sa Alkoholnom i Virusnom Cirozom Jetre Journal of Medical Biochemistry 33(2): 149-155